Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Acta Paediatr ; 96(5): 736-9, 2007 May.
Article in English | MEDLINE | ID: mdl-17381470

ABSTRACT

AIM: To evaluate clinical and genetic factors, besides pancreatic insufficiency, associated with increased risk of cystic fibrosis-related diabetes. METHODS: Case-control (1:1) study on 138 cystic fibrosis patients. Data were collected on gender, age at diagnosis, reason for cystic fibrosis diagnosis, family history of type 1 or 2 diabetes mellitus, pre-existing severe liver disease, and class of cystic fibrosis transmembrane regulation mutation. Moreover, information was obtained on lung involvement and degree of exocrine pancreatic insufficiency evaluated 1 year before the diagnosis of cystic fibrosis-related diabetes in patients and age-matched controls. RESULTS: Compared to controls, patients with cystic fibrosis-related diabetes had a higher probability of having already been diagnosed with liver disease (16.7% versus 1.7%, OR = 11.6, 95% CI 1.43-93.0). Moreover, in the year before diabetes onset, cases had slightly worse pulmonary function compared to controls (FEV1 = 58.4 +/- 27% predicted versus 67.4 +/- 21% predicted; p = 0.05). No significant effects related to the other factors considered were found. CONCLUSION: Severe liver disease was found to significantly increase the risk of developing cystic fibrosis-related diabetes. Patients with liver disease should be scheduled for earlier diabetes screening in order to identify and possibly treat glucose intolerance.


Subject(s)
Cystic Fibrosis/epidemiology , Diabetes Mellitus/epidemiology , Liver Diseases/epidemiology , Adolescent , Adult , Case-Control Studies , Comorbidity , Cystic Fibrosis/physiopathology , Diabetes Mellitus/physiopathology , Humans , Risk Factors
2.
Minerva Pediatr ; 58(5): 477-82, 2006 Oct.
Article in Italian | MEDLINE | ID: mdl-17008859

ABSTRACT

AIM: To estimate the incidence rate of hospital-acquired rotavirus infections (HRI) in a paediatric hospital in a 3-year period; the risk of HRI associated to age, sex, ward, season; the cost determined by HRI for the healthcare system. METHODS: Retrospective epidemiological study, carried out using hospital datasets, with the analysis of some clinical records. RESULTS: In the 2003-2005 period the HRI incidence rate was 1.9% (mean age 15.2 months, SD 11.8, range 1.5-49), with a decreasing trend over years. Children aged less than 8 months were at higher risk of HRI than others (RR 1.83, CI 95% 1.18-2.85) as well as were children admitted to a 0-18 months pediatric medicine ward (RR=2.84, CI 95% 1.78-4.5) and to an infectious diseases ward (RR=4.9, CI 95% 3.4-7). The incidence of HRI was higher in the winter than in the rest of the year (RR 1.59, CI 95% 1.07-2.36). The hospital stay of children with HRI was prolonged by a mean of 5.2 days compared to age, sex and comorbidity-matched controls. (P=0.02). CONCLUSIONS: The method used in this study is easily reproducible. Data obtained can be used as internal quality indicators and to evaluate the performance of different hospital wards in infection control. Infection prevention activities should involve mothers and families of hospitalized children, as they perform on them a great deal of basic care and hygiene activities which are at risk for hospital cross-infections.


Subject(s)
Cross Infection/epidemiology , Rotavirus Infections/epidemiology , Child , Child, Preschool , Female , Hospitals, Pediatric , Humans , Incidence , Infant , Male , Retrospective Studies , Risk Factors , Time Factors
5.
J Perinat Med ; 29(2): 158-62, 2001.
Article in English | MEDLINE | ID: mdl-11344676

ABSTRACT

We present the case of a full term infant affected by diffuse persistent interstitial pulmonary emphysema (PIPE), who was treated with partial liquid ventilation (PLV) after the failure of conventional management. PIPE is a lethal chronic lung disease of unclear pathogenesis. Clinical history, radiological and histological findings confirmed the diagnosis in our patient. PLV applied for 48 hours resulted in a significant improvement in the infant's respiratory function and was not associated with adverse effects. We concluded that PLV could be effective in prolonging the survival of infants with PIPE; its application represents an effective form of respiratory support in infants with chronic lung disease.


Subject(s)
Liquid Ventilation , Pulmonary Emphysema/therapy , Adult , Biopsy , Carbon Dioxide/blood , Fatal Outcome , Female , Gestational Age , Humans , Infant, Newborn , Male , Nitric Oxide/administration & dosage , Oxygen/blood , Positive-Pressure Respiration , Pregnancy , Pulmonary Emphysema/pathology , Pulmonary Emphysema/surgery , Pulmonary Surfactants/therapeutic use , Respiration, Artificial
6.
J Pediatr ; 138(3): 438-40, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11241060

ABSTRACT

To evaluate the effects of conventional phototherapy and fiberoptic phototherapy on trans-epidermal water loss in preterm infants with and without skin ointment application, 20 infants were randomly assigned to receive conventional or fiberoptic phototherapy for non-hemolytic hyperbilirubinemia. After conventional phototherapy, there were no significant differences in trans-epidermal water loss between ointment-treated and untreated areas. After fiberoptic phototherapy, trans-epidermal water loss significantly increased from ointment-treated and untreated areas, but the increase was less in treated areas.


Subject(s)
Fiber Optic Technology , Hyperbilirubinemia/therapy , Infant, Premature , Phototherapy/adverse effects , Phototherapy/methods , Water Loss, Insensible , alpha-Tocopherol/analogs & derivatives , Analysis of Variance , Humans , Incubators , Infant, Newborn , Ointments/therapeutic use , Radiation-Protective Agents/therapeutic use , Temperature , Time Factors , Tocopherols , Vitamin E/analogs & derivatives , Vitamin E/therapeutic use
7.
Early Hum Dev ; 62(1): 57-63, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11245995

ABSTRACT

BACKGROUND: The role of blood transfusions and iron intake in the pathogenesis or retinopathy of prematurity (ROP) is controversial. AIM: To evaluate the influence of packed red cell (PRC) transfusions and iron intake on ROP incidence. STUDY DESIGN: Prospective observational study. SUBJECTS: Forty-five preterm infants with birthweight <1250 g were studied. After ophthalmological study, they were divided into group A (n=24) that included newborns without ROP, and group B (n=21) that included newborns with ROP. RESULTS: Logistic regression analysis demonstrated that gestational age (OR 0.61; 95% C.I. 0.41-0.90), transfusion volume during the first week (OR 1.16; 95% C.I. 1.03-1.3) and during the first 2 months of life (OR 2.93; 95% C.I. 1.52-5.62), and iron intake during the first week of life (OR 1.15; C.I. 1.01-1.32) and during the first 2 months of life (OR 2.93; 95% C.I. 1.52-5.62) were associated with the development of ROP. CONCLUSION: Our study showed that gestational age, blood transfusion volume and iron load by transfusions are associated with the risk of occurrence of ROP in infants with a birthweight of less than 1250 g.


Subject(s)
Infant, Premature/metabolism , Iron, Dietary/adverse effects , Iron/metabolism , Retinopathy of Prematurity/etiology , Transfusion Reaction , Erythropoietin/therapeutic use , Gestational Age , Humans , Infant, Newborn , Logistic Models , Ophthalmoscopy , Prospective Studies , Retinopathy of Prematurity/epidemiology , Retinopathy of Prematurity/metabolism
8.
Acta Paediatr ; 89(11): 1369-74, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11106052

ABSTRACT

UNLABELLED: The aim of our study was to evaluate whether the prophylactic use of ibuprofen would reduce the incidence of significant patent ductus arteriosus (PDA) and to confirm the effectiveness of ibuprofen as rescue treatment in closing PDA. Eighty preterm infants with gestational age less than 34 wk with infant respiratory distress syndrome (iRDS) were randomized to receive intravenous ibuprofen lysine (10 mg/kg, followed by 5 mg/kg after 24 and 48 h) either within 24 h of life (group A) or after echocardiographic diagnosis of PDA (group B). To evaluate the severity of RDS in each patient, we calculated the initial and highest values of Oxygenation Index (O.I. = mean airway pressure x FiO2 x 100/PaO2) and Ventilatory Index (V.I. = O.I. x mechanical respiratory rate). Other studied variables were ventilatory support, renal function, biochemical and haematological profiles, frequency of bronchopulmonary dysplasia (BPD), intraventricular haemorrhage (IVH), necrotizing enterocolitis (NEC) and retinopathy of prematurity (ROP). On the 3rd day of life, 8% (3/40) of patients of group A and 53% of patients (21/40) of group B (p < 0.0001) developed a significant PDA. Between patients of group B who presented PDA at 3 d of life 90% (19/21) had a closure of ductus arteriosus after ibuprofen treatment. Initial and highest values of O.I. and V.I. were similar in both groups A and B. No significant differences between the groups were observed in regard to respiratory support, renal function and frequency of BPD, IVH, NEC and ROP. Ibuprofen was not associated with adverse effects. CONCLUSION: Prophylactic treatment with ibuprofen reduces PDA occurrence in preterm infants with iRDS at 3 d of life in comparison with rescue treatment, but both modes are effective in closing the ductus without significant adverse effects.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Cyclooxygenase Inhibitors/therapeutic use , Ductus Arteriosus, Patent/prevention & control , Ibuprofen/therapeutic use , Infant, Premature , Respiratory Distress Syndrome, Newborn/complications , Age Factors , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Apgar Score , Birth Weight , Cyclooxygenase Inhibitors/administration & dosage , Data Interpretation, Statistical , Ductus Arteriosus, Patent/diagnostic imaging , Ductus Arteriosus, Patent/epidemiology , Echocardiography, Doppler , Female , Gestational Age , Humans , Ibuprofen/administration & dosage , Incidence , Infant, Newborn , Injections, Intravenous , Male , Respiration, Artificial , Respiratory Distress Syndrome, Newborn/diagnosis , Respiratory Distress Syndrome, Newborn/therapy , Time Factors
9.
Biol Neonate ; 78(1): 27-32, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10878419

ABSTRACT

OBJECTIVE: To investigate the acute effects of low-dose caffeine and aminophylline on cerebral blood flow in preterm infants, using both near-infrared spectroscopy (NIRS) and cerebral Doppler ultrasonography. METHODS: Preterm infants with a gestational age of <32 weeks and birth weight of <1,500 g were randomized to receive either caffeine or aminophylline treatment for apnea of prematurity. The study period went from 30 min before to 60 min after the administration of the maintenance dose of pure caffeine (2.5 mg/kg once a day) or aminophylline (1.25 mg/kg twice a day). NIRS was used to measure changes in oxygenated hemoglobin (O(2)Hb), deoxygenated hemoglobin (HHb), oxidized-reduced cytochrome aa3 (CtOx), and mean cerebral oxygen saturation (SmO(2) = O(2)Hb/total Hb). Changes in cerebral blood volume (DeltaCBV) after caffeine or aminophylline administration were calculated. Cerebral blood flow velocity (CBV) in the pericallosal artery was evaluated by cerebral Doppler ultrasounds. RESULTS: Data collected by NIRS and cerebral Doppler ultrasounds did not show significant differences before and after caffeine treatment. We observed a significant increase in O(2)Hb and HHb concentration and in CBV at 30 min after the infusion of aminophylline, which tended to return to baseline at the end of the study period. CONCLUSION: Caffeine does not significantly affect brain hemodynamics, while aminophylline induces a significant transient increase in O(2)Hb and HHb concentration and CBV.


Subject(s)
Aminophylline/adverse effects , Caffeine/adverse effects , Central Nervous System Stimulants/adverse effects , Cerebrovascular Circulation/drug effects , Infant, Premature/physiology , Aminophylline/administration & dosage , Apnea/drug therapy , Birth Weight , Blood Flow Velocity/drug effects , Blood Volume/drug effects , Caffeine/administration & dosage , Central Nervous System Stimulants/administration & dosage , Electron Transport Complex IV/blood , Gestational Age , Hemoglobins/analysis , Humans , Infant, Newborn , Infant, Premature, Diseases/drug therapy , Oxygen/blood , Oxyhemoglobins/analysis , Ultrasonography, Doppler
10.
Eur Respir J ; 14(1): 155-9, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10489844

ABSTRACT

Respiratory distress syndrome (RDS) and transient tachypnoea (TT) are the most frequent acute respiratory diseases in the newborn. This study investigated the risk factors for RDS and TT in newborn infants. A population of 63,537 newborns was enrolled in a 12-month survey in Italy, 734 (1.15%) affected by RDS and 594 (0.93%) affected by TT. Multivariate regression analysis of maternal and perinatal data and the calculation of odds ratios (with 95% confidence intervals) were performed. It was demonstrated that gestational age, birthweight, maternal age, elective and emergency caesarean section (CS), and male sex were risk factors for RDS, while gestational age, maternal diseases, twinning, birthweight, operative vaginal delivery, elective and emergency CS, and male sex were risk factors for TT. The data confirm previous reports and demonstrate that advanced maternal age is a risk factor for RDS, while ruling out maternal diseases as independent risk factors for RDS.


Subject(s)
Dyspnea/etiology , Respiratory Distress Syndrome, Newborn/etiology , Adult , Birth Weight , Cesarean Section/adverse effects , Dyspnea/diagnosis , Dyspnea/epidemiology , Female , Gestational Age , Humans , Incidence , Infant, Newborn , Italy/epidemiology , Male , Maternal Age , Odds Ratio , Pregnancy , Prospective Studies , Respiratory Distress Syndrome, Newborn/diagnosis , Respiratory Distress Syndrome, Newborn/epidemiology , Risk Factors , Sex Factors , Survival Rate
12.
Acta Paediatr ; 87(12): 1261-8, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9894827

ABSTRACT

A prospective multicentre 12-month survey of neonatal respiratory disorders in 63 537 Italian infants was performed to evaluate the incidence of acute neonatal respiratory disorders and of the main related complications. A total of 1427 developed respiratory disorders (2.2%), 208 of whom died (14.6%). The incidence of respiratory distress syndrome was 1.16%, with a case fatality rate (CFR) of 24%; that of transient tachypnoea was 0.93%, with a CFR of 1.3%. The rates of meconium aspiration syndrome, persistent pulmonary hypertension and pneumonia were 0.06%, 0.02% and 0.07%, with CFRs of 10.3%, 38.5% and 21.7%, respectively. The occurrences of the main complications in affected newborns were: bronchopulmonary dysplasia 5.6%, necrotizing enterocolitis 1.7%, patent ductus arteriosus 9.8%, 3 degrees and 4 degrees grade intraventricular haemorrhage 6.8% and air leak 4.9%. It was concluded that the incidence of acute neonatal respiratory disorders and the main related complications was lower than that reported two decades ago and that the CFR of acute neonatal respiratory disorders had increased. These results may be the consequences of (i) progress in the management of high-risk pregnancies, (ii) an increased number of viable infants with extremely low birth weight and (iii) diffusion of antenatal treatment with corticosteroids which, in this series, seemed to reduce the morbidity but not the mortality in the high-risk infants.


Subject(s)
Respiratory Insufficiency/epidemiology , Acute Disease , Female , Gestational Age , Humans , Incidence , Infant, Newborn , Italy/epidemiology , Male , Prospective Studies , Respiratory Insufficiency/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...